Directory
Publications
This folder holds the following references to publications, sorted by year and author.
There are 57 references in this bibliography folder.
Dumont, C, Deas, O, Mollereau, B, Hebib, C, Giovino-Barry, V, Bernard, A, Hirsch, F, Charpentier, B, and Senik, A
(1998).
Potent apoptotic signaling and subsequent unresponsiveness induced by a single CD2 mAb (BTI-322) in activated human peripheral T cells.
J Immunol, 160(8):3797-804.
Mailhos, C, Andre, S, Mollereau, B, Goriely, A, Hemmati-Brivanlou, A, and Desplan, C
(1998).
Drosophila Goosecoid requires a conserved heptapeptide for repression of paired-class homeoprotein activators.
Development, 125(5):937-47.
Deas, O, Dumont, C, Mollereau, B, Metivier, D, Pasquier, C, Bernard-Pomier, G, Hirsch, F, Charpentier, B, and Senik, A
(1997).
Thiol-mediated inhibition of FAS and CD2 apoptotic signaling in activated human peripheral T cells.
Int Immunol, 9(1):117-25.
Mollereau, B, Blanchard, D, Deas, O, Dumont, C, Metivier, D, Bernard, A, McGrew, JT, Charpentier, B, Vazquez, A, and Senik, A
(1997).
Relationship between proliferation and susceptibility to CD95- and CD2-mediated apoptosis in stimulated primary T lymphocytes: T cells manifesting proliferative unresponsiveness are preferentially susceptible to CD95-mediated apoptosis.
J Immunol, 159(6):2668-77.
Rouleau, M, Mollereau, B, Bernard, A, Metivier, D, Rosenthal-Allieri, MA, Charpentier, B, and Senik, A
(1997).
CD2 induced apoptosis of peripheral T cells.
Transplant Proc, 29(5):2377-8.
Mollereau, B, Deckert, M, Deas, O, Rieux-Laucat, F, Hirsch, F, Bernard, A, Fischer, A, Lynch, DH, Charpentier, B, Le Deist, F, and Senik, A
(1996).
CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylation.
J Immunol, 156(9):3184-90.
Rouleau, M, Mollereau, B, Bernard, A, Metivier, D, Rosenthal-Allieri, MA, Charpentier, B, and Senik, A
(1994).
Mitogenic CD2 monoclonal antibody pairs predispose peripheral T cells to undergo apoptosis on interaction with a third CD2 monoclonal antibody.
J Immunol, 152(10):4861-72.
Document Actions
